APA (7th ed.) Citation

Alhamadani, F., Zhang, K., Parikh, R., Wu, H., Rasmussen, T. P., Bahal, R., . . . Manautou, J. E. (2022). Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs. Drug metabolism and disposition, 50(6), 879-887. https://doi.org/10.1124/dmd.121.000418

Chicago Style (17th ed.) Citation

Alhamadani, Feryal, Kristy Zhang, Rajvi Parikh, Hangyu Wu, Theodore P. Rasmussen, Raman Bahal, Xiao-bo Zhong, and José E. Manautou. "Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs." Drug Metabolism and Disposition 50, no. 6 (2022): 879-887. https://doi.org/10.1124/dmd.121.000418.

MLA (9th ed.) Citation

Alhamadani, Feryal, et al. "Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs." Drug Metabolism and Disposition, vol. 50, no. 6, 2022, pp. 879-887, https://doi.org/10.1124/dmd.121.000418.